SCHEMBL6956331

SCHEMBL6956331

O=c1oc(-c2ccc(OCCc3ccccc3)cc2)cc(O)c1SCCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 0.46
ACHE P22303 3/20 0.46
BCHE P06276 2/20 0.43
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
FFAR1 O14842 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
ABCB1 P08183 4/20 0.41
PTGER4 P35408 1/20 0.40
MAPT P10636 1/20 0.40
NPC1 O15118 1/20 0.40
MAOA P21397 4/20 0.40
MAOB P27338 4/20 0.40
PRKDC P78527 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960907 0.94 ACHE (0.42) SLC16A3ACHEBCHEABCB1MAPT
SCHEMBL6958378 0.94 MAOA (0.45) SLC16A3ACHEBCHEFFAR1ABCB1
SCHEMBL6952547 0.91 ABCB1 (0.50) SLC16A3ACHEBCHEFFAR1ABCB1
SCHEMBL6954320 0.89 SLC16A3 (0.44) SLC16A3ACHEBCHERAB9AMEN1
SCHEMBL6956259 0.89 XDH (0.48) ABCB1MAPTL3MBTL1
SCHEMBL6957097 0.89 CYSLTR1 (0.41) ACHEBCHEFFAR1ABCB1MAPT
SCHEMBL6963318 0.87 CYP1A1 (0.38) ACHEBCHEFFAR1ABCB1MAPT
SCHEMBL6954657 0.87 SMN1; SMN2 (0.44) MEN1KMT2ACA12CA1CA2
SCHEMBL6960622 0.87 SMN1; SMN2 (0.49) RAB9AMEN1KMT2ACA12CA1
SCHEMBL6956148 0.86 PTGES (0.45) ACHEBCHERAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed